Embecta Corp. Cash Flow Statement
EMBC / Health Care|6 years of annual SEC 10-K data (FY2020-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 6 fiscal years. All figures from audited SEC 10-K filings.
Embecta Corp. generated $192M in operating cash flow and $182M in free cash flow in FY2025. Free cash flow margin was 16.9% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income | $95.4M | $78.3M | $70.4M | $223.6M | $414.8M | $427.6M |
| Depreciation & Amortization | $40.7M | $36.2M | $32.6M | $31.7M | $38.3M | $38.3M |
| Operating Cash Flow | $191.7M | $35.7M | $67.7M | $412.2M | $456.3M | $498.5M |
| Capital Expenditures | $9.3M | $15.8M | $26.5M | $23.6M | $36.8M | $41.9M |
| Free Cash Flow | $182.4M | $19.9M | $41.2M | $388.6M | $419.5M | $456.6M |
| Dividends Paid | $35.0M | $34.5M | $34.4M | $8.6M | $0 | $0 |
| FCF Margin | 16.9% | 1.8% | 3.7% | 34.4% | 36.0% | 42.1% |